UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11778) 11778
Newsletter (56) 56
Magazine Article (23) 23
Book Chapter (21) 21
Conference Proceeding (6) 6
Newspaper Article (5) 5
Web Resource (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11358) 11358
rituximab (9631) 9631
science & technology (9136) 9136
life sciences & biomedicine (8970) 8970
female (5993) 5993
male (5739) 5739
antibodies, monoclonal, murine-derived (5647) 5647
middle aged (4729) 4729
adult (3852) 3852
antibodies, monoclonal - therapeutic use (3697) 3697
aged (3688) 3688
antibodies, monoclonal, murine-derived - therapeutic use (3282) 3282
treatment outcome (3181) 3181
biological and medical sciences (2840) 2840
hematology (2784) 2784
medical sciences (2784) 2784
oncology (2588) 2588
antineoplastic combined chemotherapy protocols - therapeutic use (2570) 2570
antibodies, monoclonal, murine-derived - administration & dosage (1893) 1893
antineoplastic agents - therapeutic use (1789) 1789
antibodies, monoclonal - administration & dosage (1644) 1644
aged, 80 and over (1477) 1477
immunologic factors - therapeutic use (1469) 1469
cyclophosphamide - administration & dosage (1422) 1422
animals (1396) 1396
hematologic and hematopoietic diseases (1358) 1358
lymphoma, large b-cell, diffuse - drug therapy (1318) 1318
abridged index medicus (1227) 1227
prognosis (1146) 1146
antineoplastic combined chemotherapy protocols - administration & dosage (1143) 1143
vincristine - administration & dosage (1139) 1139
retrospective studies (1119) 1119
cyclophosphamide - therapeutic use (1088) 1088
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (1087) 1087
doxorubicin - administration & dosage (1079) 1079
antibodies, monoclonal, murine-derived - adverse effects (1041) 1041
antineoplastic agents (1040) 1040
remission induction (999) 999
care and treatment (998) 998
prednisone - administration & dosage (991) 991
immunology (984) 984
rheumatology (983) 983
adolescent (974) 974
antibodies, monoclonal - adverse effects (970) 970
immunosuppressive agents - therapeutic use (961) 961
young adult (925) 925
cancer (919) 919
mice (919) 919
pharmacology. drug treatments (888) 888
prednisone - therapeutic use (887) 887
lymphomas (886) 886
disease-free survival (857) 857
recurrence (826) 826
chemotherapy (820) 820
medicine & public health (820) 820
lymphoma (813) 813
vincristine - therapeutic use (801) 801
immunotherapy (799) 799
follow-up studies (781) 781
doxorubicin - therapeutic use (773) 773
antigens, cd20 - immunology (755) 755
lymphoma, b-cell - drug therapy (749) 749
transplantation (730) 730
b-lymphocytes - immunology (725) 725
monoclonal antibodies (710) 710
lymphoma, non-hodgkin - drug therapy (662) 662
combined modality therapy (658) 658
antirheumatic agents - therapeutic use (657) 657
drug therapy (657) 657
drug therapy, combination (654) 654
antineoplastic combined chemotherapy protocols - adverse effects (629) 629
time factors (625) 625
antineoplastic agents - administration & dosage (619) 619
tumors (610) 610
general & internal medicine (609) 609
lymphoma, large b-cell, diffuse - pathology (598) 598
medicine, general & internal (586) 586
immunohistochemistry (573) 573
arthritis, rheumatoid - drug therapy (563) 563
lymphoma, follicular - drug therapy (562) 562
child (561) 561
risk factors (553) 553
antibodies, monoclonal - pharmacology (535) 535
analysis (534) 534
antineoplastic agents - adverse effects (534) 534
research (531) 531
antimitotic agents (529) 529
b-lymphocytes - drug effects (528) 528
drug administration schedule (528) 528
leukemia, lymphocytic, chronic, b-cell - drug therapy (523) 523
hemic and lymphatic diseases (519) 519
health aspects (497) 497
cyclophosphamide (480) 480
antibodies, monoclonal, murine-derived - pharmacology (474) 474
neoplasm staging (471) 471
survival analysis (470) 470
clinical trials as topic (447) 447
survival rate (440) 440
antibodies (439) 439
antibodies, monoclonal, murine-derived - immunology (430) 430
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11085) 11085
Japanese (355) 355
French (176) 176
Chinese (158) 158
German (146) 146
Spanish (124) 124
Russian (55) 55
Italian (30) 30
Portuguese (24) 24
Hungarian (23) 23
Polish (21) 21
Czech (15) 15
Danish (15) 15
Croatian (11) 11
Dutch (9) 9
Norwegian (8) 8
Finnish (7) 7
Hebrew (7) 7
Korean (4) 4
Serbian (3) 3
Romanian (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 25, pp. 5996 - 6004
Journal Article
Journal Article
Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 18, pp. 3160 - 3164
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 196 - 206
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Organ Transplantation - pathology | Cyclophosphamide - therapeutic use | Epstein-Barr Virus Infections - therapy | Vincristine - administration & dosage | Adult | Female | Herpesvirus 4, Human - pathogenicity | Prednisolone - therapeutic use | France | Lymphoproliferative Disorders - etiology | Doxorubicin - administration & dosage | Antigens, CD20 - immunology | Rituximab | Lymphoproliferative Disorders - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organ Transplantation - adverse effects | Adolescent | Vincristine - therapeutic use | Epstein-Barr Virus Infections - diagnosis | Lymphoproliferative Disorders - drug therapy | Aged | Germany | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Organ transplant recipients | Clinical trials | Product development | Epstein-Barr virus | Universities and colleges | Prednisolone | Cancer | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Lymphoproliferative Disorders | Antineoplastic Combined Chemotherapy Protocols | Organ Transplantation | Vincristine | Doxorubicin | Herpesvirus 4, Human | Life Sciences | Immunology | Epstein-Barr Virus Infections
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2011, Volume 155, Issue 4, pp. 498 - 508
Journal Article